Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study

por Hosseini, Faezeh Sadat, Amanlou, Massoud
Publicado 2020

Tankyrase Inhibitor for Cardiac Tissue Regeneration: an In-silico Approach

por Hosseini, Faezeh Sadat, Amanlou, Arash, Amanlou, Massoud
Publicado 2021

Discovery of novel inhibitors of ghrelin O-acyltransferase enzyme: an in-silico approach

por Hosseini, Faezeh Sadat, Ghassempour, Alireza, Amanlou, Massoud
Publicado 2022

Synthesis, molecular docking, and antiepileptic activity of novel phthalimide derivatives bearing amino acid conjugated anilines

por Asadollahi, Azar, Asadi, Mehdi, Hosseini, Faezeh Sadat, Ekhtiari, Zeinab, Biglar, Mahmood, Amanlou, Massoud
Publicado 2019

Indole alkaloids as potential candidates against COVID-19: an in silico study

por Mohseni, Mehran, Bahrami, Hamed, Farajmand, Bahman, Hosseini, Faezeh Sadat, Amanlou, Massoud, Salehabadi, Hafezeh
Publicado 2022

Design, synthesis, and evaluation of novel racecadotril-tetrazole-amino acid derivatives as new potent analgesic agents

por Asadi, Mehdi, Mohammadi-Khanaposhtani, Maryam, Hosseini, Faezeh Sadat, Gholami, Mahdi, Dehpour, Ahmad Reza, Amanlou, Massoud
Publicado 2021

Isoindolin-1-ones Fused to Barbiturates: From Design and Molecular Docking to Synthesis and Urease Inhibitory Evaluation

por Kazemzadeh, Houman, Hamidian, Elham, Hosseini, Faezeh Sadat, Abdi, Movahed, Niasari Naslaji, Fatemeh, Talebi, Meysam, Asadi, Mehdi, Biglar, Mahmood, Zarei, Issa, Amanlou, Massoud
Publicado 2022

Imidazo[1,2-c]quinazolines as a novel and potent scaffold of α-glucosidase inhibitors: design, synthesis, biological evaluations, and in silico studies

por Peytam, Fariba, Hosseini, Faezeh sadat, Hekmati, Malak, Bayati, Bahareh, Moghadam, Mahdis Sadeghi, Emamgholipour, Zahra, Firoozpour, Loghman, Mojtabavi, Somayeh, Faramarzi, Mohammad Ali, Sadat-Ebrahimi, Seyed Esmaeil, Tehrani, Maliheh Barazandeh, Foroumadi, Alireza
Publicado 2023